Jacobsen syndrome

Mattina, Teresa; Perrotta, Concetta Simona; Grossfeld, Paul
January 2009
Orphanet Journal of Rare Diseases;2009, Vol. 4, p1
Academic Journal
Jacobsen syndrome is a MCA/MR contiguous gene syndrome caused by partial deletion of the long arm of chromosome 11. To date, over 200 cases have been reported. The prevalence has been estimated at 1/100,000 births, with a female/male ratio 2:1. The most common clinical features include pre- and postnatal physical growth retardation, psychomotor retardation, and characteristic facial dysmorphism (skull deformities, hypertelorism, ptosis, coloboma, downslanting palpebral fissures, epicanthal folds, broad nasal bridge, short nose, v-shaped mouth, small ears, low set posteriorly rotated ears). Abnormal platelet function, thrombocytopenia or pancytopenia are usually present at birth. Patients commonly have malformations of the heart, kidney, gastrointestinal tract, genitalia, central nervous system and skeleton. Ocular, hearing, immunological and hormonal problems may be also present. The deletion size ranges from ∼7 to 20 Mb, with the proximal breakpoint within or telomeric to subband 11q23.3 and the deletion extending usually to the telomere. The deletion is de novo in 85% of reported cases, and in 15% of cases it results from an unbalanced segregation of a familial balanced translocation or from other chromosome rearrangements. In a minority of cases the breakpoint is at the FRA11B fragile site. Diagnosis is based on clinical findings (intellectual deficit, facial dysmorphic features and thrombocytopenia) and confirmed by cytogenetics analysis. Differential diagnoses include Turner and Noonan syndromes, and acquired thrombocytopenia due to sepsis. Prenatal diagnosis of 11q deletion is possible by amniocentesis or chorionic villus sampling and cytogenetic analysis. Management is multi-disciplinary and requires evaluation by general pediatrician, pediatric cardiologist, neurologist, ophthalmologist. Auditory tests, blood tests, endocrine and immunological assessment and follow-up should be offered to all patients. Cardiac malformations can be very severe and require heart surgery in the neonatal period. Newborns with Jacobsen syndrome may have difficulties in feeding and tube feeding may be necessary. Special attention should be devoted due to hematological problems. About 20% of children die during the first two years of life, most commonly related to complications from congenital heart disease, and less commonly from bleeding. For patients who survive the neonatal period and infancy, the life expectancy remains unknown.


Related Articles

  • Heparin-Induced Thrombocytopenia (HIT). Conley, Kim // MEDSURG Nursing;Dec99, Vol. 8 Issue 6, p355 

    Deals with heparin-induced thrombocytopenia, a complication of heparin therapy (HIT) that can cause arterial and venous thrombosis. Pathophysiology; Signs, symptoms and sequela; Diagnosis of HIT; Therapeutic interventions.

  • immune thrombocytopenic purpura:. Huber, Jeffrey T.; Gillaspy, Mary L. // Encyclopedic Dictionary of AIDS-Related Terminology;2000, p116 

    The term "immune thrombocytopenic purpura" is defined as a form of purpura occurring as a result of a disturbance in the immune system in which the platelet count is reduced. An example of this is an infection with the HIV.

  • Danaparoid sodium/enoxaparin sodium.  // Reactions Weekly;8/31/2013, Issue 1467, p13 

    The article presents the case of a 72-year-old man who developed heparin-induced thrombocytopenia (HIT) with acute abdominal aortic stentgraft thrombosis while receiving enoxaparin sodium.

  • Sunitinib.  // Reactions Weekly;Nov2014, Vol. 1527 Issue 1, p198 

    The article presents the case of a man, who experienced grade 3 thrombocytopenia following therapy with sunitinib.

  • Gabapentin.  // Reactions Weekly;Oct2015, Vol. 1572 Issue 1, p102 

    The article presents a case study of a 33-year-old man who developed thrombocytopenia while being treated with gabapentin for complex partial seizures.

  • Heparin-induced thrombocytopenia and cardiopulmonary bypass: anticoagulation with unfractionated heparin and the GPIIb/IIIa inhibitor tirofiban and successful use of rFVIIa for post-protamine bleeding due to persistent platelet blockade. Durand, Marion; Lecompte, Thomas; Hacquard, Marie; Carteaux, Jean-Pierre // European Journal of Cardio-Thoracic Surgery;Sep2008, Vol. 34 Issue 3, p687 

    Abstract: Heparin-induced thrombocytopenia was diagnosed in a 50-year-old man on day 5 after cardiac surgery (aorto-coronary bypass and mitral valve replacement). He required redo (para-prosthesis leak) on day 13. The cardiopulmonary bypass (CPB) was performed with unfractionated heparin (UFH)...

  • Warfarin Skin Necrosis of the Upper Extremity in a Patient with Heparin-Induced Thrombocytopenia. Syrek, Jennifer R.; Calligaro, Keith D.; Dougherty, Matthew J.; DeLaurentis, Dominic A. // Vascular Surgery;May/Jun1998, Vol. 32 Issue 3, p291 

    A case of heparin-induced thrombocytopenia and warfarin skin necrosis is reported in a 62-year-old man treated for a subclavian venous thrombosis. These two complications occurring in the same patient have been reported only on two other occasions. Warfarin skin necrosis affecting the upper...

  • PRV-1 mRNA expression discriminates two types of essential thrombocythemia. Griesshammer, M.; Klippel, S.; Strunck, E.; Temerinac, S.; Mohr, U.; Heimpel, H.; Pahl, H. L. // Annals of Hematology;Jun2004, Vol. 83 Issue 6, p364 

    Essential thrombocythemia (ET) is a heterogeneous disorder. For example, the growth of erythropoietin-independent erythroid colonies, termed “endogenous erythroid colonies (EECs)”, has previously been observed in only 50% of ET patients. We have recently described the overexpression...

  • Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines Gurbuz, Ahmet Tayfun; Elliott, William G.; Zia, Ayhan A. // European Journal of Cardio-Thoracic Surgery;Jan2005, Vol. 27 Issue 1, p138 

    Summary: Heparin-induced thrombocytopenia/thrombosis is an immunologic reaction to unfractionated heparin characterized by thrombocytopenia, platelet activation and thrombosis. A high index of suspicion is required for timely diagnosis and treatment. Treatment is complex and outcome maybe less...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics